Results 241 to 250 of about 41,154 (301)
History of Psychopharmacology [PDF]
Annual Review of Clinical Psychology, 2019 We live in an age of psychopharmacology. One in six persons currently takes a psychotropic drug. These drugs have profoundly shaped our scientific and cultural understanding of psychiatric disease.
Joel T Braslow, Stephen R Marder
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Clinics of North America, 2014
Primary care providers (PCPs) are frequently responsible for the pharmacologic management of mood disorders, and the PCP is often an important member of the clinical team in the management of bipolar disorder and schizophrenia. Not only is a good understanding of psychopharmacology important for the effective treatment of psychiatric disease, it is ...
L Renata, Thronson +1 more
openaire +2 more sources
Primary care providers (PCPs) are frequently responsible for the pharmacologic management of mood disorders, and the PCP is often an important member of the clinical team in the management of bipolar disorder and schizophrenia. Not only is a good understanding of psychopharmacology important for the effective treatment of psychiatric disease, it is ...
L Renata, Thronson +1 more
openaire +2 more sources
Italian Journal of Dermatology and Venereology, 2018
Most dermatologists evaluate and treat patients with psychological or psychiatric issues related to their skin disease. These patients often require psychopharmacologic therapies. Therefore, it is important for dermatologists to be familiar with psychopharmacologic treatments for diseases that fit into the overlap between psychiatry and dermatology ...
Sahil, Sekhon +2 more
openaire +2 more sources
Most dermatologists evaluate and treat patients with psychological or psychiatric issues related to their skin disease. These patients often require psychopharmacologic therapies. Therefore, it is important for dermatologists to be familiar with psychopharmacologic treatments for diseases that fit into the overlap between psychiatry and dermatology ...
Sahil, Sekhon +2 more
openaire +2 more sources
Pharmacological Research, 2001
Emission tomography techniques and, in particular, positron emission tomography (PET) enable the in vivo study of several physiological and neurochemical variables in human subjects using methods originally developed for quantitative autoradiography. In particular, PET allows one to evaluate in human subjects: (a) the effect of specific neurochemical ...
MORESCO, ROSA MARIA +7 more
openaire +5 more sources
Emission tomography techniques and, in particular, positron emission tomography (PET) enable the in vivo study of several physiological and neurochemical variables in human subjects using methods originally developed for quantitative autoradiography. In particular, PET allows one to evaluate in human subjects: (a) the effect of specific neurochemical ...
MORESCO, ROSA MARIA +7 more
openaire +5 more sources
Ethnicity and Psychopharmacology
Psychiatric Clinics of North America, 1986In clinical studies and cross-national surveys, cultural or ethnic factors have been found to be significant determinants in patients' responses to psychotropic medication. Dosage requirements and the potential for toxic reactions might differ amongst racial and ethnic groups.
K M, Lin, R E, Poland, I M, Lesser
openaire +2 more sources
Journal of Psychopharmacology, 2023 The British Association for Psychopharmacology course on child and adolescent psychopharmacology has been run for more than 20 years and is currently a very popular course, attracting around 140 delegates/year from across the United Kingdom and abroad ...
Samuele Cortese +2 more
exaly +3 more sources
Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II [PDF]
Journal of PsychopharmacologyAs Faculty of the British Association for Psychopharmacology course on child and adolescent psychopharmacology, we present here what we deem are the most common pitfalls, and how to avoid them, in child and adolescent psychopharmacology.
Samuele Cortese +2 more
exaly +2 more sources
Psychopharmacology for Neurologists
Seminars in Neurology, 2009Psychiatric disorders are common in neurological patients, and psychopharmacological agents are frequently used to treat agitation and other problems in neurological practice. Antidepressants are effective for depression caused by neurological illness, but they can interact with other medications. Antianxiety drugs can aggravate cognitive disorders and
Steven L, Dubovsky, Amelia N, Dubovsky
openaire +2 more sources
Psychopharmacology for the elderly
Progress in Neuro-Psychopharmacology, 1981Abstract 1. 1. The use of tricyclic antidepressant agents in the elderly is limited by their anticholinergic and cardiovascular action. Newer compounds, such as mianserin, maprotiline and trazadone may provide advantages in this respect. 2. 2.
W M, Petrie, T A, Ban
openaire +2 more sources
NeuroRehabilitation, 1993
This article examines the use of compounds classified as “cognitive activators” to treat cognitive deficits from neurologic disorders, particularly brain injury. The compounds reviewed include catecholamine agonists, cholinergic agonists, nootropics, gangliosides, and thyrotropin releasing hormone (TRH).
A, McLean +3 more
openaire +2 more sources
This article examines the use of compounds classified as “cognitive activators” to treat cognitive deficits from neurologic disorders, particularly brain injury. The compounds reviewed include catecholamine agonists, cholinergic agonists, nootropics, gangliosides, and thyrotropin releasing hormone (TRH).
A, McLean +3 more
openaire +2 more sources